Lorian Hardcastle
دانشیار · Regulation and governance of the health care system
University of Calgaryمعرفی
Lorian Hardcastle serves as Associate Professor at the University of Calgary's Faculty of Law with a joint appointment in the Department of Community Health Sciences at the Cumming School of Medicine. She maintains critical affiliations with the One Health Consortium, O'Brien Institute for Public Health, and Conjoint Health Research Ethics Board, positioning her at the intersection of legal and health system governance.
Academic Background:
- Doctor of Judicial Science (SJD), University of Toronto (2014)
- LLM, University of Toronto (2006)
- JD with Health Law and Policy Specialization Certificate, Dalhousie Law School (2004)
- Fellowship, O'Neill Institute for National and Global Health Law, Georgetown University
Her research critically examines healthcare regulation, liability frameworks, and public health policy with emphasis on patient safety and system accountability. Recent work demonstrates increasing focus on digital health governance, pandemic response mechanisms, and pharmaceutical policy within evolving trade agreements, reflecting urgent contemporary challenges. Publications consistently bridge legal theory with actionable policy solutions across law reviews, health policy journals, and major Canadian media outlets.
Research Impact: Current projects address antimicrobial resistance (Alberta Major Innovation Fund), AI in health (CIHR), long-term care regulation, and COVID-19 legal issues, demonstrating sustained relevance to public health crises. Her op-eds in the Globe and Mail, Toronto Star, and provincial journals directly inform policy debates.
Honors:
- Teaching Excellence Award, University of Calgary Students' Union (2020)
- Teaching Excellence Award, University of Calgary Students' Union (2019)
Professor Hardcastle supervises directed research students while leading interdisciplinary collaborations through the One Health Consortium and O'Brien Institute. Her scholarship on virtual care regulation, long-term care accountability, and pharmaceutical policy continues to shape Canadian health law discourse through both academic publications and real-time policy engagement.
